Companies and Brands

Procter & Gamble Q2 Earnings: What to Expect

Chris Lange

Published: January 25, 2016 1:35 pm

Last Updated: January 13, 2020 2:37 pm

Procter & Gamble Co. (NYSE: PG) is scheduled to release its fiscal second-quarter financial results before the markets open on Tuesday. The consensus estimates from Thomson Reuters call for $0.98 in earnings per share (EPS) on $16.95 billion in revenues. In the same period of the previous year, the company posted EPS of $0.95 and revenue of $20.16 billion.

The stock lost about 10% in 2015, and the company’s restructuring hasn’t seemed to help. Procter & Gamble still wants to get rid of more product groups to focus on core and growth markets. Now it yields around 3.3%, but its valuation at roughly 18 times earnings just doesn’t feel cheap yet. Maybe it can have a better 2016, as analysts are looking for a 5% price gain, before taking the yield into consideration.

This is a solid consumer staples stock, especially for conservative investors to consider. It sells lots of run-of-the-mill household items that are essential for everyday life, but it is not content to stand pat on its laurels.

The company actually is innovative in its product development process and uses that to help ensure future growth and cash flow. This should provide investors years of steady growth and dividends. While currency headwinds have weighed on recent earnings and projections, the dollar may be topping out would bode very well for the future.

24/7 Wall St.
Deutsche Bank Has 4 Play-It-Safe Stocks to Buy for Volatile Markets

• Stifel upgraded it to a Buy rating from a Hold with an $85 price target.
• Atlantic Securities initiated coverage with a Neutral rating and an $84 price target.
• Canaccord Genuity reiterated a Hold rating with an $82 price target.

So far in 2016, this company has outperformed the broad markets, with the stock down only 1.7%. Over the past 52 weeks, the stock is down over 12%.

Shares of Procter & Gamble were trading down 0.4% at $77.08 on Monday, with a consensus analyst price target of $83.11 and a 52-week trading range of $65.02 to $89.95.